Zolmitriptan Spray
Product Images NDC 71335-2947
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 71335-2947). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
Figure 3 (Image 03)
This text provides a comparison between Zolmitriptan 5 mg and a placebo based on the estimated probability of rescue medication use over time post-dose. The study involved 231 participants for Zolmitriptan and 253 for the placebo. The information implies a potential analysis of the effectiveness of Zolmitriptan in reducing the need for rescue medication compared to a placebo.*
Figure-a (Image 04)
Figure B (Image 05)
Figure-c (Image 06)
Figure D (Image 07)
Chemical-structure (Image 10)
Label (Lbl713352947)
This is a description of a nasal spray medication containing 5 mg of Zolmitriptan in a unit dose aqueous solution. The solution is buffered with citric acid and contains other pharmaceutical ingredients. It is recommended for intranasal use only, and caution is advised to keep it out of reach of children. The dosage information is available in the package insert, and the medication should be stored within a specific temperature range. The product is labeled with a national drug code, manufacturer information, and prescription details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.